The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of the randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients (pts) with relapsed or refractory multiple myeloma (RRMM): COLUMBA.
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
 
Hareth Nahi
No Relationships to Disclose
 
Wojciech Legiec
No Relationships to Disclose
 
Sebastian Grosicki
No Relationships to Disclose
 
Vladimir Vorobyev
Speakers' Bureau - Astellas Pharma; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Janssen; Roche; Takeda
 
Ivan Spicka
Consulting or Advisory Role - Amgen; Janssen-Cilag; Novartis; Takeda
Speakers' Bureau - Amgen; Janssen-Cilag; Novartis; Takeda
Research Funding - Amgen; Celgene
 
Vania TM Hungria
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen
 
Sibirina Korenkova
Research Funding - Janssen; Karyopharm Therapeutics; Takeda
Travel, Accommodations, Expenses - Janssen
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Janssen Biotech
Consulting or Advisory Role - Abbvie; Celgene; Janssen
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Janssen
 
Max Flogegard
No Relationships to Disclose
 
Joan Blade
Honoraria - Amgen; Celgene; Janssen; Takeda
 
Philippe Moreau
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda
 
Martin Kaiser
Honoraria - Amgen; Celgene; Janssen Oncology; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Chugai Pharma; Janssen Oncology; Takeda
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Takeda
 
Shinsuke Iida
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - Janssen; Ono Pharmaceutical; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Chugai Pharma; Daiichi Sankyo; Janssen; Kyowa Hakko Kirin; MSD; Novartis; Ono Pharmaceutical; Sanofi; Takeda
 
Jacob Laubach
Consulting or Advisory Role - Celgene; Novartis; Takeda
Research Funding - Celgene; Millennium; Novartis; Onyx
 
Tahamtan Ahmadi
Employment - Genmab
Stock and Other Ownership Interests - Genmab; Johnson & Johnson
 
Dolly A. Parasrampuria
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Lixian Peng
Employment - Janssen
 
Ming Qi
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Seagen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Pharmacyclics; Sanofi; Seagen